Literature DB >> 23554378

CD133+ hematopoietic progenitor cells harbor HIV genomes in a subset of optimally treated people with long-term viral suppression.

Lucy A McNamara1, Adewunmi Onafuwa-Nuga, Nadia T Sebastian, James Riddell, Dale Bixby, Kathleen L Collins.   

Abstract

BACKGROUND: Hematopoietic progenitor cells (HPCs) in the bone marrow of human immunodeficiency virus (HIV)-infected individuals have been proposed as a persistent reservoir of virus. However, some studies have suggested that HIV genomes detected in HPCs arise from T-cell contamination.
METHODS: CD133-sorted HPCs and CD133-depleted bone marrow cells were purified from bone marrow specimens obtained from 11 antiretroviral-treated donors in whom the HIV load had been <48 copies/mL for at least 6 months. CD133 and CD3 expression on the cells was assessed by flow cytometry. HIV DNA was quantified by real-time polymerase chain reaction analysis.
RESULTS: HIV genomes were detected in CD133-sorted samples from 6 donors, including 2 in whom viral loads were undetectable for >8 years. CD3(+) T cells represented <1% of cells in all CD133-sorted samples. For 5 of 6 CD133-sorted samples with detectable HIV DNA, the HIV genomes could not be explained by contaminating CD3(+) T cells. Donors with detectable HIV DNA in HPCs received their diagnosis significantly more recently than the remaining donors but had had undetectable viral loads for similar periods.
CONCLUSIONS: HIV genomes can be detected in CD133-sorted cells from a subset of donors with long-term viral suppression and, in most cases, cannot be explained by contamination with CD3(+) T cells.

Entities:  

Keywords:  HIV; hematopoietic progenitor cells; reservoirs

Mesh:

Substances:

Year:  2013        PMID: 23554378      PMCID: PMC3654754          DOI: 10.1093/infdis/jit118

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  29 in total

1.  Presence of CXCR4-using HIV-1 in patients with recently diagnosed infection: correlates and evidence for transmission.

Authors:  Kristen Chalmet; Kenny Dauwe; Lander Foquet; Franky Baatz; Carole Seguin-Devaux; Bea Van Der Gucht; Dirk Vogelaers; Linos Vandekerckhove; Jean Plum; Chris Verhofstede
Journal:  J Infect Dis       Date:  2011-12-05       Impact factor: 5.226

2.  Dynamics of HIV tropism under suppressive antiretroviral therapy: implications for tropism testing in subjects with undetectable viraemia.

Authors:  Eduardo Seclén; María Del Mar González; Carmen De Mendoza; Vincent Soriano; Eva Poveda
Journal:  J Antimicrob Chemother       Date:  2010-05-20       Impact factor: 5.790

Review 3.  HIV persistence and the prospect of long-term drug-free remissions for HIV-infected individuals.

Authors:  Didier Trono; Carine Van Lint; Christine Rouzioux; Eric Verdin; Françoise Barré-Sinoussi; Tae-Wook Chun; Nicolas Chomont
Journal:  Science       Date:  2010-07-09       Impact factor: 47.728

4.  Detection of quasispecies variants predicted to use CXCR4 by ultra-deep pyrosequencing during early HIV infection.

Authors:  Isabella Abbate; Chrysoula Vlassi; Gabriella Rozera; Alessandro Bruselles; Barbara Bartolini; Emanuela Giombini; Angela Corpolongo; Gianpiero D'Offizi; Pasquale Narciso; Alessandro Desideri; Giuseppe Ippolito; Maria R Capobianchi
Journal:  AIDS       Date:  2011-03-13       Impact factor: 4.177

5.  HIV-1 utilizes the CXCR4 chemokine receptor to infect multipotent hematopoietic stem and progenitor cells.

Authors:  Christoph C Carter; Lucy A McNamara; Adewunmi Onafuwa-Nuga; Mark Shackleton; James Riddell; Dale Bixby; Michael R Savona; Sean J Morrison; Kathleen L Collins
Journal:  Cell Host Microbe       Date:  2011-03-17       Impact factor: 21.023

6.  HIV-1 infects multipotent progenitor cells causing cell death and establishing latent cellular reservoirs.

Authors:  Christoph C Carter; Adewunmi Onafuwa-Nuga; Lucy A McNamara; James Riddell; Dale Bixby; Michael R Savona; Kathleen L Collins
Journal:  Nat Med       Date:  2010-03-07       Impact factor: 53.440

7.  Emergence and persistence of CXCR4-tropic HIV-1 in a population of men from the multicenter AIDS cohort study.

Authors:  James C Shepherd; Lisa P Jacobson; Wei Qiao; Beth D Jamieson; John P Phair; Paolo Piazza; Thomas C Quinn; Joseph B Margolick
Journal:  J Infect Dis       Date:  2008-10-15       Impact factor: 5.226

8.  Analysis of human immunodeficiency virus type 1 viremia and provirus in resting CD4+ T cells reveals a novel source of residual viremia in patients on antiretroviral therapy.

Authors:  Timothy P Brennan; John O Woods; Ahmad R Sedaghat; Janet D Siliciano; Robert F Siliciano; Claus O Wilke
Journal:  J Virol       Date:  2009-06-17       Impact factor: 5.103

9.  The impact of HIV tropism on decreases in CD4 cell count, clinical progression, and subsequent response to a first antiretroviral therapy regimen.

Authors:  Laura Waters; Sundhiya Mandalia; Paul Randell; Adrian Wildfire; Brian Gazzard; Graeme Moyle
Journal:  Clin Infect Dis       Date:  2008-05-15       Impact factor: 9.079

10.  HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation.

Authors:  Nicolas Chomont; Mohamed El-Far; Petronela Ancuta; Lydie Trautmann; Francesco A Procopio; Bader Yassine-Diab; Geneviève Boucher; Mohamed-Rachid Boulassel; Georges Ghattas; Jason M Brenchley; Timothy W Schacker; Brenna J Hill; Daniel C Douek; Jean-Pierre Routy; Elias K Haddad; Rafick-Pierre Sékaly
Journal:  Nat Med       Date:  2009-06-21       Impact factor: 53.440

View more
  24 in total

1.  Hematopoietic stem cells and HIV infection.

Authors:  Matthew Pace; Una O'Doherty
Journal:  J Infect Dis       Date:  2013-04-03       Impact factor: 5.226

Review 2.  Targeting HIV latency: resting memory T cells, hematopoietic progenitor cells and future directions.

Authors:  Nadia T Sebastian; Kathleen L Collins
Journal:  Expert Rev Anti Infect Ther       Date:  2014-09-04       Impact factor: 5.091

3.  HIV-1 infection of hematopoietic progenitor cells in vivo in humanized mice.

Authors:  Christopher C Nixon; Dimitrios N Vatakis; Scott N Reichelderfer; Dhaval Dixit; Sohn G Kim; Christel H Uittenbogaart; Jerome A Zack
Journal:  Blood       Date:  2013-07-25       Impact factor: 22.113

4.  Vpr overcomes macrophage-specific restriction of HIV-1 Env expression and virion production.

Authors:  Michael Mashiba; David R Collins; Valeri H Terry; Kathleen L Collins
Journal:  Cell Host Microbe       Date:  2014-11-26       Impact factor: 21.023

5.  Hematopoietic Stem and Progenitor Cells (HSPCs).

Authors:  Valeri H Terry; Gretchen E Zimmerman; Maria C Virgilio; Mark M Painter; Dale Bixby; Kathleen L Collins
Journal:  Methods Mol Biol       Date:  2022

6.  Telmisartan increases vascular reparative capacity in older HIV-infected adults: a pilot study.

Authors:  Jordan E Lake; Sophie Seang; Theodoros Kelesidis; Judith S Currier; Otto O Yang
Journal:  HIV Clin Trials       Date:  2016-09-23

Review 7.  Tissue reservoirs of HIV.

Authors:  Joseph K Wong; Steven A Yukl
Journal:  Curr Opin HIV AIDS       Date:  2016-07       Impact factor: 4.283

8.  Quiescence Promotes Latent HIV Infection and Resistance to Reactivation from Latency with Histone Deacetylase Inhibitors.

Authors:  Mark M Painter; Thomas D Zaikos; Kathleen L Collins
Journal:  J Virol       Date:  2017-11-30       Impact factor: 5.103

9.  Long-lived reservoirs of HIV-1.

Authors:  Thomas D Zaikos; Kathleen L Collins
Journal:  Trends Microbiol       Date:  2014-03-15       Impact factor: 17.079

Review 10.  Bioinformatics and HIV latency.

Authors:  Angela Ciuffi; Pejman Mohammadi; Monica Golumbeanu; Julia di Iulio; Amalio Telenti
Journal:  Curr HIV/AIDS Rep       Date:  2015-03       Impact factor: 5.071

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.